DalsnaFinance

Neuronetics Inc $STIM

Health Care

Pennsylvania
Create a scorecard
$1.97
-0.01 (-0.51%)
As of Oct 21, 2026, 10:07 AM EDT
Price history
Loading chart…

Neuronetics Inc (STIM) is trading down at $1.97 (-0.51%), as of the latest quote. It operates in the Health Care sector.

IPO: June 28, 2018 · $17.00 offering · NASDAQ · View IPO details →

Neuronetics Inc revenue & net income history (FY2016–FY2025)

RevenueNet incomeNet margin (right axis, %)
$149.2M$52.7M−$43.7MFY2016 revenue: $34.2MFY2016 net income: −$11.2M · Net margin −32.8%'16FY2017 revenue: $40.4MFY2017 net income: −$16.1M · Net margin −39.7%'17FY2018 revenue: $52.8MFY2018 net income: −$24.1M · Net margin −45.7%'18FY2019 revenue: $62.7MFY2019 net income: −$29.0M · Net margin −46.4%'19FY2020 revenue: $49.2MFY2020 net income: −$27.5M · Net margin −55.7%'20FY2021 revenue: $55.3MFY2021 net income: −$31.2M · Net margin −56.4%'21FY2022 revenue: $65.2MFY2022 net income: −$37.2M · Net margin −57.0%'22FY2023 revenue: $71.3MFY2023 net income: −$30.2M · Net margin −42.3%'23FY2024 revenue: $74.9MFY2024 net income: −$43.7M · Net margin −58.4%'24FY2025 revenue: $149.2MFY2025 net income: −$39.0M · Net margin −26.1%'25−36.6%0%50%FY2016 net margin: −32.8%FY2017 net margin: −39.7% (off the scale, which stops at −36.6%)FY2018 net margin: −45.7% (off the scale, which stops at −36.6%)FY2019 net margin: −46.4% (off the scale, which stops at −36.6%)FY2020 net margin: −55.7% (off the scale, which stops at −36.6%)FY2021 net margin: −56.4% (off the scale, which stops at −36.6%)FY2022 net margin: −57.0% (off the scale, which stops at −36.6%)FY2023 net margin: −42.3% (off the scale, which stops at −36.6%)FY2024 net margin: −58.4% (off the scale, which stops at −36.6%)FY2025 net margin: −26.1%
Neuronetics Inc annual financial statements
FY2016Dec 2016FY2017Dec 2017FY2018Dec 2018FY2019Dec 2019FY2020Dec 2020FY2021Dec 2021FY2022Dec 2022FY2023Dec 2023FY2024Dec 2024FY2025Dec 2025
Income statement
Revenue$34.2M$40.4M$52.8M$62.7M$49.2M$55.3M$65.2M$71.3M$74.9M$149.2M
Growth (year over year)—+18.1%+30.5%+18.7%−21.4%+12.3%+17.9%+9.4%+5.0%+99.2%
Gross profit$27.6M$30.8M$40.3M$47.3M$37.7M$43.7M$49.7M$51.7M$54.2M$72.3M
Gross margin80.7%76.2%76.4%75.4%76.5%78.9%76.3%72.5%72.3%48.5%
Operating income−$9.34M−$13.6M−$19.8M−$26.9M−$22.3M−$27.6M−$35.1M−$30.6M−$34.6M−$31.4M
Operating margin−27.3%−33.7%−37.6%−43.0%−45.3%−49.8%−53.8%−42.8%−46.2%−21.1%
Net income−$11.2M−$16.1M−$24.1M−$29.0M−$27.5M−$31.2M−$37.2M−$30.2M−$43.7M−$39.0M
Net margin−32.8%−39.7%−45.7%−46.4%−55.7%−56.4%−57.0%−42.3%−58.4%−26.1%
EPS (diluted)−$76.95−$86.34−$2.69−$1.58−$1.46−$1.22−$1.38−$1.05−$1.38−$0.59
Balance sheet
Cash and equivalents$17.0M$29.1M$104.6M$75.7M$49.0M$94.1M$70.3M$59.7M$18.5M$28.1M
Total assets—$38.9M$117.0M$100.2M$78.7M$141.2M$116.9M$115.8M$140.9M$141.6M
Total liabilities—$44.5M$46.0M$52.3M$53.2M$56.0M$59.8M$81.6M$109.1M$115.3M
Long-term debt—$29.6M$30.4M$19.9M$34.6M$35.3M$22.8M$59.3M$55.2M$65.8M
Shareholders' equity−$177.1M−$192.7M$71.0M$47.9M$25.5M$85.2M$57.1M$34.2M$27.7M$22.4M
Cash flow
Operating cash flow−$8.54M−$11.1M−$20.6M−$30.5M−$28.4M−$28.0M−$30.7M−$32.0M−$31.0M−$20.4M
Capital expenditure$324.0K$594.0K$1.01M$813.0K$730.0K$2.35M$3.27M$2.37M$1.47M$801.0K
Free cash flow−$8.87M−$11.7M−$21.6M−$31.3M−$29.1M−$30.3M−$34.0M−$34.4M−$32.5M−$21.2M

From Neuronetics Inc's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

About Neuronetics Inc

Headquarters
Malvern, Pennsylvania From SEC filings, Oct 2026

Recent News (1)

More Health Care stocks

Browse all companies →